Introduction. Failure of fluoroquinolones, the principal treatment option for macrolide-resistant Mycoplasma genitalium infections, has recently emerged. This is of particular concern for men who have sex with men (MSM), who have high proportions of macrolide-resistant M. genitalium infections. Treatment failure with moxifloxacin is likely the result of single nucleotide polymorphisms (SNPs) in parC, whilst concurrent gyrA mutations may play a role.
Gap Statement. The levels of fluoroquinolone resistance and dual-class (i.e. macrolide and fluoroquinolone) resistance in M. genitalium among asymptomatic MSM is unknown.
Aim. To (i) determine the proportion of fluoroquinolone resistance and dual-class resistance in M. genitalium infections among asymptomatic MSM, (ii) explore any clinical and behavioural associations with fluoroquinolone resistance, and (iii) determine the distribution of antibiotic resistance among M. genitalium mgpB sequence types (STs).
Methodology.M. genitalium positive samples (N=94) were obtained from 1001 asymptomatic MSM enrolled in a study at Melbourne Sexual Health Centre (Carlton, Australia) between August 2016 and September 2017. Sanger sequencing was performed to determine the proportion of M. genitalium infections with SNPs in parC that have previously been associated with failure of moxifloxacin (corresponding to amino changes S83I, D83R, D87Y and D87N) and in gyrA (corresponding to amino acid changes M95I, D99N, D99Y and D99G). Associations between clinical/behavioural factors and parC SNPs were examined. Strain typing was performed by sequencing a portion of the mgpB gene.
Results. The proportion of MSM with infections harbouring parC and gyrA SNPs was 13.0 % [95 % confidence interval (CI): 6.8–23.2 %] and 4.7 % (95 % CI: 1.1–13.4 %), respectively; dual-class resistance was 13.0 %. No significant clinical/behavioural associations were found. Antibiotic resistance was not restricted to specific mgpB STs.
Conclusion. One in eight (13 %) of asymptomatic MSM with M. genitalium had an infection with dual-class-resistance mutations. Typing by mgpB sequence suggested fluoroquinolone resistance is arising from independent mutation events. This study illustrates that asymptomatic MSM may act as a reservoir for antibiotic-resistant M. genitalium.
This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Fernández-HuertaM, BarberáMJ, EsperalbaJ, Fernandez-NavalC, Vall-MayansM et al. Prevalence of Mycoplasma genitalium and macrolide resistance among asymptomatic people visiting a point of care service for rapid STI screening: a cross-sectional study. Sex Transm Infect2020; 96:300–305 [View Article] [PubMed]
BerçotB, CharreauI, RousseauC, DelaugerreC, ChidiacC et al. High prevalence and high rate of antibiotic resistance of Mycoplasma genitalium infections in men who have sex with men: a substudy of the ANRS IPERGAY pre-exposure prophylaxis trial. Clin Infect Dis2020ciaa1832 [View Article] [PubMed]
ReadTRH, MurrayGL, DanielewskiJA, FairleyCK, DoyleM et al. Symptoms, sites, and significance of Mycoplasma genitalium in men who have sex with men. Emerg Infect Dis2019; 25:719–727 [View Article] [PubMed]
BradshawCS, FairleyCK, ListerNA, ChenSJ, GarlandSM et al.Mycoplasma genitalium in men who have sex with men at male-only saunas. Sex Transm Infect2009; 85:432–435 [View Article] [PubMed]
FrancisSC, KentCK, KlausnerJD, RauchL, KohnR et al. Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006. Sex Transm Dis2008; 35:797–800 [View Article] [PubMed]
SoniS, AlexanderS, VerlanderN, SaundersP, RichardsonD et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect2010; 86:21–24 [View Article] [PubMed]
ZhengB, YinY, HanY, ShiM, JianN et al. The prevalence of urethral and rectal Mycoplasma genitalium among men who have sex with men in China, a cross-sectional study. BMC Public Health2014; 14:195 [View Article] [PubMed]
CouldwellDL, JaloconD, PowerM, JeoffreysNJ, ChenSCA et al.Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney. Sex Transm Infect2018; 94:406–410 [View Article] [PubMed]
CrowellTA, LawlorJ, LombardiK, NowakRG, HardickJ et al. Anorectal and urogenital Mycoplasma genitalium in Nigerian men who have sex with men and transgender women: prevalence, incidence, and association with HIV. Sex Transm Dis2020; 47:202–206 [View Article] [PubMed]
LatimerRL, ShillingHS, VodstrcilLA, MachalekDA, FairleyCK et al. Prevalence of Mycoplasma genitalium by anatomical site in men who have sex with men: a systematic review and meta-analysis. Sex Transm Infect2020; 96:563–570 [View Article] [PubMed]
BradleyI, VarmaR, KnightV, IliakisD, McNallyL et al. Prevalence of rectal Mycoplasma genitalium and macrolide resistance in men who have sex with men attending Sydney Sexual Health Centre. Sex Health2020; 17:114–120 [View Article] [PubMed]
BissessorM, TabriziSN, BradshawCS, FairleyCK, HockingJS et al. The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men. Clin Microbiol Infect2016; 22:260–265 [View Article] [PubMed]
OngJJ, AungE, ReadTRH, FairleyCK, GarlandSM et al. Clinical characteristics of anorectal Mycoplasma genitalium infection and microbial cure in men who have sex with men. Sex Transm Dis2018; 45:522–526 [View Article] [PubMed]
MachalekDA, TaoY, ShillingH, JensenJS, UnemoM et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect Dis2020; 20:1302–1314 [View Article] [PubMed]
DurukanD, ReadTRH, MurrayG, DoyleM, ChowEPF et al. Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. Clin Infect Dis2020; 71:1461–1468 [View Article] [PubMed]
LiY, LeWJ, LiS, CaoYP, SuXH. Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS2017; 28:1106–1114 [View Article] [PubMed]
DeguchiT, MaedaS, TamakiM, YoshidaT, IshikoH et al. Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. J Antimicrob Chemother2001; 48:742–744 [View Article] [PubMed]
CouldwellDL, TaggKA, JeoffreysNJ, GilbertGL. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS2013; 24:822–828 [View Article] [PubMed]
BaetselierD, KenyonC, Vanden BergheW, SmetH, WoutersK et al. An alarming high prevalence of resistance associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015-2018. Sex Transm Infect2021; 97:297–303 [View Article] [PubMed]
ShimadaY, DeguchiT, NakaneK, MasueT, YasudaM et al. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int J Antimicrob Agents2010; 36:255–258 [View Article] [PubMed]
NguyenLT, SchmidtHA, von HaeselerA, MinhBQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol2015; 32:268–274 [View Article] [PubMed]
KalyaanamoorthyS, MinhBQ, WongTKF, von HaeselerA, JermiinLS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods2017; 14:587–589 [View Article] [PubMed]
PiñeiroL, IdigorasP, CillaG. Molecular typing of Mycoplasma genitalium-positive specimens discriminates between persistent and recurrent infections in cases of treatment failure and supports contact tracing. Microorganisms2019; 7:609 [View Article]
LatimerRL, VodstrcilL, PetraD, FairleyCK, ReadTR et al. Extragenital Mycoplasma genitalium infections among men who have sex with men. Sex Transm Infect2020; 96:10–18 [View Article] [PubMed]
OngJJ, RuanL, LimAG, BradshawCS, Taylor-RobinsonD et al. Impact of screening on the prevalence and incidence of Mycoplasma genitalium and its macrolide resistance in men who have sex with men living in Australia: a mathematical model. EClinicalMedicine2021; 33:100779 [View Article] [PubMed]
BodiyabaduK, DanielewskiJ, GarlandSM, MachalekDA, BradshawCS et al. Detection of parC gene mutations associated with quinolone resistance in Mycoplasma genitalium: evaluation of a multiplex real-time PCR assay. J Med Microbiol2021; 70:001257 [View Article] [PubMed]
CazanaveC, CharronA, RenaudinH, BébéarC. Method comparison for molecular typing of French and Tunisian Mycoplasma genitalium-positive specimens. J Med Microbiol2012; 61:500–506 [View Article] [PubMed]
GuiraudJ, LounnasM, BoissièreA, Le RoyC, ElgueroE et al. Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France. J Antimicrob Chemother2021; 76:43–47 [View Article]
DumkeR, RustM, GlaunsingerT. MgpB types among Mycoplasma genitalium strains from men who have sex with men in Berlin, Germany, 2016-2018. Pathogens2020; 9:12 [View Article]